Rosuvastatin calcium is an anti hyperlipidemic drug, which is a HMG CoA reductase inhibitor. It is successfully developed by AstraZeneca in the UK. It is suitable for the treatment of a variety of lipid disorders, including hypercholesterolemia, mixed lipid disorders and simple hypertriglyceridemia. Rosuvastatin calcium is one of the most effective and comprehensive lipid-lowering drugs on the market. Compared with the most effective atorvastatin in the world, rosuvastatin calcium has better effects in reducing LDL-C and increasing HDL-C, and has better tolerance, lower side effects and unique pharmacokinetic characteristics. Its half-life is about 20h, Just take it once a day.
Manufacturing
